Status
Conditions
Treatments
About
The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Previous treatment with NovoTTF-200T for more than 1 week at day of enrollment
198 participants in 1 patient group
Loading...
Central trial contact
Giovanni Ceresoli
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal